Tests:Gentamicin: Difference between revisions
Tests:Gentamicin
No edit summary |
Updated method Alinity |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 16: | Line 16: | ||
Garamycin | Garamycin | ||
|- | |||
|Availability | |||
|Monday - Sunday, testing routinely available out of hours | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 24: | Line 27: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen | |Specimen | ||
|Serum | |Serum | ||
Plasma | Plasma | ||
|- | |- | ||
|Preferred | |Preferred | ||
| Line 39: | Line 39: | ||
|6 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | |6 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | ||
|- | |- | ||
| | |Unacceptable | ||
|<span style="background:#99e6b3"> Li-Hep Microtainer </span> | |Grossly haemolysed specimens | ||
|- | |||
|Specimen Transportation | |||
| | |||
|- | |||
|Paediatric Requirements | |||
|<span style="background:#99e6b3"> Li-Hep Microtainer </span> | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample | |Sample | ||
|Plasma or Serum | |Plasma or Serum | ||
|- | |||
|Preferred Volume | |||
|0.5 mL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
| | | | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
| Line 55: | Line 64: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 61: | Line 70: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Alinity | |Abbott Alinity c series analyser using Abbott reagents. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 70: | Line 79: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" |State time of last dose and time of sampling on request form. | | colspan="2" |State time of last dose and time of sampling on request form. | ||
| Line 78: | Line 87: | ||
It is rarely necessary to routinely monitor aminoglycoside levels during the first 48 hours. | It is rarely necessary to routinely monitor aminoglycoside levels during the first 48 hours. | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||